$0.72
2.23% today
Nasdaq, Apr 25, 07:18 pm CET
ISIN
US67577C1053
Symbol
OCGN
Sector
Industry

Ocugen Inc Stock price

$0.74
+0.10 15.61% 1M
-0.16 17.52% 6M
-0.07 8.46% YTD
-0.44 37.55% 1Y
-1.74 70.29% 3Y
+0.43 136.87% 5Y
-512.26 99.86% 10Y
Nasdaq, Closing price Thu, Apr 24 2025
+0.02 2.78%
ISIN
US67577C1053
Symbol
OCGN
Sector
Industry

Key metrics

Market capitalization $215.19m
Enterprise Value $189.18m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 46.60
P/S ratio (TTM) P/S ratio 53.00
P/B ratio (TTM) P/B ratio 7.25
Revenue growth (TTM) Revenue growth 187.79%
Revenue (TTM) Revenue $4.06m
EBIT (operating result TTM) EBIT $-54.76m
Free Cash Flow (TTM) Free Cash Flow $-45.53m
Cash position $58.51m
EPS (TTM) EPS $-0.18
P/E forward negative
Short interest 22.91%
Show more

Is Ocugen Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,790 stocks worldwide.

Ocugen Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Ocugen Inc forecast:

4x Buy
100%

Analyst Opinions

4 Analysts have issued a Ocugen Inc forecast:

Buy
100%

Financial data from Ocugen Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
4.06 4.06
188% 188%
100%
- Direct Costs 1.97 1.97
103% 103%
49%
2.09 2.09
375% 375%
51%
- Selling and Administrative Expenses 23 23
25% 25%
560%
- Research and Development Expense 32 32
15% 15%
791%
-53 -53
22% 22%
-1,300%
- Depreciation and Amortization 1.97 1.97
103% 103%
49%
EBIT (Operating Income) EBIT -55 -55
20% 20%
-1,349%
Net Profit -54 -54
16% 16%
-1,331%

In millions USD.

Don't miss a Thing! We will send you all news about Ocugen Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Ocugen Inc Stock News

Neutral
GlobeNewsWire
17 days ago
MALVERN, Pa., April 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer, and Co-founder of Ocugen will present at the 2025 Cell & Gene Meeting on the Mediterranean being held April 15-17, 2025 at the Rome Cavalieri...
Neutral
GlobeNewsWire
about one month ago
MALVERN, Pa., March 18, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Data and Safety Monitoring Board (DSMB) for the OCU200 clinical trial recently convened and reviewed safety data following dosing of the first cohort in the dose-escalation portion of the Ph...
Neutral
Seeking Alpha
about 2 months ago
Ocugen, Inc. (NASDAQ:OCGN ) Q4 2024 Earnings Conference Call March 5, 2025 8:30 AM ET Company Participants Tiffany Hamilton - Head, Corporate Communications Shankar Musunuri - Chairman, Chief Executive Officer & Co-Founder Ramesh Ramachandran - Chief Accounting Officer Huma Qamar - Chief Medical Officer Conference Call Participants Michael Okunewitch - Maxim Group Swayampakula Ramakanth - H.C. ...
More Ocugen Inc News

Company Profile

Ocugen, Inc. engages in the development and commercialization of therapies for eye diseases. Its pipeline includes OCU400, OCU410, OCU200, OCU200, and OCU300. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA.

Head office United States
CEO Shankar Musunuri
Employees 95
Founded 2013
Website www.ocugen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today